Search Result "NS3.4A serine protease"
Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease
Journal: Infectious Disorders - Drug Targets
Volume: 6 Issue: 1 Year: 2006 Page: 3-16
Author(s): C. Lin, A. D. Kwong, R. B. Perni
Hepatitis C Virus NS3/4A Protease Inhibitors
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 3 Issue: 3 Year: 2008 Page: 157-167
Author(s): Francesc-Xavier Lopez-Labrador
Proteases as Anti-Cancer Targets - Molecular and Biological Basis for Development of Inhibitor-Like Drugs Against Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 7 Year: 2009 Page: 728-762
Author(s): A. Bialas, P. Kafarski
QSAR Analysis and Molecular Docking Simulation of Suggested Peptidomimetic NS3 Protease Inhibitors
Journal: Current Computer-Aided Drug Design
Volume: 10 Issue: 1 Year: 2014 Page: 28-40
Author(s): Hamdy I.A. Mostafa,Nihal. S. El-bialy,Ahmed A. Ezat,Noha. A. Saleh,Medhat A. Ibrahim
Direct-Acting Antiviral Drugs for Treatment of Hepatitis C Virus Infection-Clinical Trials Data and Chemistry of NS3/4a Protease Inhibitors
Ebook: Frontiers in Clinical Drug Research: Anti-Infectives
Volume: 6 Year: 2020
Author(s): Milan Sencanski,Sanja Glisic
Doi: 10.2174/9789811425745120060001
ABT-450: A Novel Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 2 Year: 2014 Page: 3261-3270
Author(s): Ivan Gentile, Federico Borgia, Antonio Riccardo Buonomo, Emanuela Zappulo, Giuseppe Castaldo, Guglielmo Borgia
Development of Anti-Viral Agents Using Molecular Modeling and Virtual Screening Techniques
Journal: Infectious Disorders - Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 64-93
Author(s): Johannes Kirchmair, Simona Distinto, Klaus Roman Liedl, Patrick Markt, Judith Maria Rollinger, Daniela Schuster, Gudrun Maria Spitzer, Gerhard Wolber
Subject Index To Volume 6
Journal: Infectious Disorders - Drug Targets
Volume: 7 Issue: 1 Year: 2007 Page: vii-vii
Author(s): Bentham Science Publishers
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 12 Year: 2014 Page: 1391-1404
Author(s): I. Gentile,F. Borgia,N. Coppola,A.R. Buonomo,G. Castaldo,G. Borgia
Synthesis of β-amino-α-ketoamides
Journal: Current Organic Chemistry
Volume: 18 Issue: 1 Year: 2014 Page: 2240-2269
Author(s): Samir Kher, Aigars Jirgensons